How Mesothelioma Cell Heterogeneity Impacts Treatment Options

Mesothelioma is a rare and aggressive cancer primarily caused by asbestos exposure. Tumor sizes vary and often contain different types of cancer cells, known as mesothelioma cell heterogeneity. Learn more about how research on cell heterogeneity is paving the way for more personalized and effective care strategies.

Lung cancer patients are often diagnosed during the advanced stages, such as stage 4. This late diagnosis often impacts a patient's treatment options and survival rate.

Turkey tail mushrooms are a type of wild mushroom that has gained popularity in the medical world due to its numerous benefits for cancer patients and the general population.

With so many options available, it can be tough to know where and who to turn to when seeking care for lung cancer. Our list of the 10 best lung cancer hospitals can provide some guidance.

While there is currently no guaranteed cure for mesothelioma, early detection and effective treatments may offer some patients a chance at remission. Effective treatments include surgery, chemotherapy, immunotherapy, and multimodal therapies. As researchers continue to search for a cure, doctors recommend anyone at high risk of developing mesothelioma undergo regular screenings.

The University of Oxford, Francis Crick Institute, and University College London have begun developing what could be the world’s first lung cancer vaccine. The vaccine will train the immune system to recognize and kill lung cancer cells in hopes of lowering lung cancer-related deaths.

Artificial intelligence is transforming the medical field, particularly in the detection and treatment of lung cancer. With its advanced technology, AI is providing better outcomes for patients. In this article, we will explore how AI is changing the landscape of lung cancer detection and care.

Chemo brain slows the brain's cognitive function throughout chemotherapy treatments. Many patients compare this to having a mental fog. Learn how to help your chemo brain symptoms here.

Clinical trials provide options for those diagnosed with severe conditions such as mesothelioma and lung cancer. We gathered five new lung cancer and mesothelioma clinical trials accepting patients in 2023.

Adagrasib is the newest inhibitor drug for the treatment of KRAS-G12C mutated non-small cell lung cancer has been approved by the FDA. Mirati Therapeutics brings adagrasib to the market as an oral drug to help late-stage NSCLC patient's prognosis.

The top 5 most deadly cancers among men and women include lung cancer, mesothelioma, colon cancer, breast cancer, and pancreatic cancer. Learn more about the deadliest cancers, their treatment options, and their causes.